Heramed Ltd Total Assets
Heramed Ltd total assets. Based on the latest financial reports, Heramed Ltd (HMD) holds total assets worth AU$1.04 Million AUD (≈ $734.01K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see HMD stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Heramed Ltd (2016–2024)
Total assets of Heramed Ltd from 2016 to 2024. This chart illustrates how Heramed Ltd's total assets have evolved over time, based on quarterly financial data. See Heramed Ltd (HMD) stock price for real-time trading data and today's change.
Heramed Ltd - Asset Composition Analysis
Heramed Ltd Total Assets Breakdown (December 2024)
Heramed Ltd total assets breakdown as of December 2024. Heramed Ltd's total assets of AU$1.04 Million consist of 82.8% current assets and 17.2% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 112.7% |
| Accounts Receivable | AU$162.18K | 5.8% |
| Inventory | AU$374.83K | 13.5% |
| Property, Plant & Equipment | AU$37.68K | 1.4% |
| Intangible Assets | AU$732.88K | 26.4% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Heramed Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Heramed Ltd to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Heramed Ltd's current assets represent 82.8% of total assets in 2024, an increase from 82.3% in 2016.
- Cash Position: Cash and equivalents constituted 112.7% of total assets in 2024, up from 77.9% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 26.0% of total assets, an increase from 16.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 26.4% of total assets.
Heramed Ltd Competitors by Total Assets
Key competitors of Heramed Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Ningbo David Medical Device Co Ltd
SHE:300314
|
China | CN¥1.47 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
OssDsign AB
ST:OSSD
|
Sweden | Skr377.50 Million |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €46.32 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$21.59 Million |
Heramed Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.04 | 1.74 | 5.17 |
| Quick Ratio | 2.33 | 1.48 | 5.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$686.82K | AU$639.15K | AU$2.01 Million |
Heramed Ltd - Advanced Valuation Insights
This section examines the relationship between Heramed Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 77.33 |
| Latest Market Cap to Assets Ratio | 10.50 |
| Asset Growth Rate (YoY) | 37.8% |
| Total Assets | AU$2.78 Million |
| Market Capitalization | $29.16 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Heramed Ltd's assets at a significant premium (10.50x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Heramed Ltd's assets grew by 37.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Heramed Ltd (2016–2024)
The table below shows the annual total assets of Heramed Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | AU$2.78 Million ≈ $1.96 Million |
+37.78% |
| 2023-12-31 | AU$2.01 Million ≈ $1.43 Million |
-51.91% |
| 2022-12-31 | AU$4.19 Million ≈ $2.96 Million |
-8.44% |
| 2021-12-31 | AU$4.57 Million ≈ $3.24 Million |
+44.11% |
| 2020-12-31 | AU$3.17 Million ≈ $2.25 Million |
-11.96% |
| 2019-12-31 | AU$3.61 Million ≈ $2.55 Million |
-15.60% |
| 2018-12-31 | AU$4.27 Million ≈ $3.02 Million |
+242.42% |
| 2017-12-31 | AU$1.25 Million ≈ $882.84K |
-27.77% |
| 2016-12-31 | AU$1.73 Million ≈ $1.22 Million |
-- |
About Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the … Read more